-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Warfarin and Heparin Monitoring in Antiphospholipid Syndrome

Program: Education Program
Session: Anticoagulation SOS: Navigating Monitoring Conundrums
Hematology Disease Topics & Pathways:
Clinical Practice (Health Services and Quality), Education
Monday, December 9, 2024, 10:30 AM-11:45 AM

Hannah Cohen, MD

University College London Hospitals NHS Foundation Trust, London, United Kingdom

Disclosures: Cohen: UCB Biopharma: Consultancy, Other: paid to UCL Hospital Charity; Technoclone: Consultancy, Other: paid to UCL Hospital Charity; Roche: Membership on an entity's Board of Directors or advisory committees; argenx: Membership on an entity's Board of Directors or advisory committees; GlaxoSmithKlein: Honoraria.

See more of: Anticoagulation SOS: Navigating Monitoring Conundrums
See more of: Education Program
<< Previous Presentation | Next Presentation